78 related articles for article (PubMed ID: 9164124)
1. Costs and consequences of ESRD in NC.
Norman M; Young H; Bell RA
N C Med J; 1997; 58(3):165. PubMed ID: 9164124
[No Abstract] [Full Text] [Related]
2. Losartan reduces the costs associated with nephropathy and end-stage renal disease from type 2 diabetes: Economic evaluation of the RENAAL study from a Canadian perspective.
Burgess ED; Carides GW; Gerth WC; Marentette MA; Chabot I;
Can J Cardiol; 2004 May; 20(6):613-8. PubMed ID: 15152291
[TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus: implications, costs and issues.
Lowe H
West Indian Med J; 2001 Mar 1-4; 50 Suppl 1():13-4. PubMed ID: 15973806
[No Abstract] [Full Text] [Related]
4. Managed care is not the "cure-all" for improving quality and controlling costs in ESRD.
Amerling R
Nephrol News Issues; 1999 Apr; 13(4):46-7. PubMed ID: 10418448
[No Abstract] [Full Text] [Related]
5. ESRD as a window into America's cost crisis in health care.
Knauf F; Aronson PS
J Am Soc Nephrol; 2009 Oct; 20(10):2093-7. PubMed ID: 19729435
[No Abstract] [Full Text] [Related]
6. Slowing the progression of chronic renal insufficiency.
Crowley S
N C Med J; 2000; 61(2):80-3. PubMed ID: 10737028
[No Abstract] [Full Text] [Related]
7. HMOs and ESRD: a gloomy scenario.
Steinman TI
Nephrol News Issues; 1998 May; 12(5 Suppl):30, 33. PubMed ID: 9652298
[No Abstract] [Full Text] [Related]
8. Telemedicine project looks to improve ESRD care, lower costs. TRC/Georgetown University Medical Center begin two-year experiment.
Neumann ME
Nephrol News Issues; 1997 Oct; 11(10):67-9. PubMed ID: 9391397
[No Abstract] [Full Text] [Related]
9. Diabetes mellitus: an imperative for prevention and intense management.
Prisant LM
J Clin Pharmacol; 2004 Apr; 44(4):394-6. PubMed ID: 15051747
[No Abstract] [Full Text] [Related]
10. Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis.
Nissenson AR; Dylan ML; Griffiths RI; Yu HT; Dean BB; Danese MD; Dubois RW
Am J Kidney Dis; 2005 Aug; 46(2):301-8. PubMed ID: 16112049
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and costs of chronic kidney disease in North Carolina.
Vupputuri S
N C Med J; 2008; 69(3):205-7. PubMed ID: 18751353
[No Abstract] [Full Text] [Related]
12. A patient-directed fee-for-service system can work for ESRD.
Amerling R
Nephrol News Issues; 2002 Sep; 16(10):25-6. PubMed ID: 12271926
[No Abstract] [Full Text] [Related]
13. The impact of losartan on the lifetime incidence of ESRD and costs in Mexico.
Arredondo A; Burke TA; Carides GW; Lemus E; Querol J
Rev Invest Clin; 2005; 57(3):399-405. PubMed ID: 16187699
[TBL] [Abstract][Full Text] [Related]
14. Inadequate funding from payers will doom ESRD capitation.
Day LM
Nephrol News Issues; 1998 May; 12(5 Suppl):32, 34. PubMed ID: 9652299
[No Abstract] [Full Text] [Related]
15. Drugs take the spotlight in steering clinical, economic direction for ESRD.
Neumann ME
Nephrol News Issues; 2004 Jun; 18(7):50-1. PubMed ID: 15232997
[No Abstract] [Full Text] [Related]
16. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
Prodjosudjadi W
Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
[TBL] [Abstract][Full Text] [Related]
17. Primary kidney disease and post-renal transplantation hospitalization costs.
Ghoddousi K; Ramezani MK; Assari S; Lankarani MM; Amini M; Khedmat H; Hollisaaz MT
Transplant Proc; 2007 May; 39(4):962-5. PubMed ID: 17524863
[TBL] [Abstract][Full Text] [Related]
18. An improved understanding of the causes of end-stage renal disease.
Young EW
Semin Nephrol; 1997 May; 17(3):170-5. PubMed ID: 9165646
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of angiotensin receptor blockers in type 2 diabetes, hypertension, and nephropathy.
Ravera M; Re M; Vettoretti S
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S44-8. PubMed ID: 16565246
[TBL] [Abstract][Full Text] [Related]
20. How should developing countries manage diabetes?
Narayan KM; Zhang P; Williams D; Engelgau M; Imperatore G; Kanaya A; Ramachandran A
CMAJ; 2006 Sep; 175(7):733. PubMed ID: 17001048
[No Abstract] [Full Text] [Related]
[Next] [New Search]
